Thomas Lycan
Wake Forest Baptist Comprehensive Cancer Center · Wake Forest Baptist Health Sciences · Wake Forest University Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Lycan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:00 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05984680 · COPD Care Pathway Among Patients With CancerWake Forest University Health Sciences · completed · Chronic Obstructive Pulmonary Disease, Lung Cancer, Head and Neck Cancer · principal investigator
- Ph2NCT05696782 · Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung CancerWake Forest University Health Sciences · recruiting · Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Stage II · principal investigator
- Ph2NCT04858269 · First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma PatientsWake Forest University Health Sciences · active not recruiting · Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma · principal investigator
- Ph2NCT04253964 · Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/ImmunotherapyWake Forest University Health Sciences · recruiting · Nonsmall Cell Lung Cancer, Performance Status · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Prevention and Control Research ProgramP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · fiscal years 2000 to 2026
- CTSA K12 Program at Wake ForestK12TR004931 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicholette D. Allred · fiscal years 2024 to 2026Named on NCT05984680
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:00 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: a controlled clinical trial.Diabetes Educ · 200867 citationsRCR 2.0
- A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.PLoS One · 201657 citationsRCR 1.7
- Lack of energy compensation over 4 days when white button mushrooms are substituted for beef.Appetite · 200818 citationsRCR 0.7
- 2 citationsRCR 0.4
- Just-in-Time Teaching (JiTT) Screencasts: a Randomized Controlled Trial of Asynchronous Learning on an Inpatient Hematology-Oncology Teaching Service.J Cancer Educ · 20221 citationsRCR 0.2
- Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer: A Nonrandomized Clinical Trial.JAMA Otolaryngol Head Neck Surg · 2026